GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Accounts Payable & Accrued Expense

CASBF (CanSino Biologics) Accounts Payable & Accrued Expense : $58.63 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Accounts Payable & Accrued Expense?

CanSino Biologics's quarterly accounts payable & accrued expense increased from Mar. 2024 ($82.58 Mil) to Jun. 2024 ($87.00 Mil) but then declined from Jun. 2024 ($87.00 Mil) to Dec. 2024 ($58.63 Mil).

CanSino Biologics's annual accounts payable & accrued expense increased from Dec. 2022 ($120.79 Mil) to Dec. 2023 ($134.77 Mil) but then declined from Dec. 2023 ($134.77 Mil) to Dec. 2024 ($58.63 Mil).

CanSino Biologics Accounts Payable & Accrued Expense Historical Data

The historical data trend for CanSino Biologics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Accounts Payable & Accrued Expense Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only 42.62 224.12 120.79 134.77 58.63

CanSino Biologics Quarterly Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.61 134.77 82.58 87.00 58.63

CanSino Biologics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CanSino Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
HKSE:00570 HKSE:01558 HKSE:02005 HKSE:01681 HKSE:00460 HKSE:02186 HKSE:03613 HKSE:01349 HKSE:02877 HKSE:02561 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
06185:Hong Kong CJH:Germany 688185:China
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
Website
https://www.cansinotech.com
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.